EAHP 2014, innovation, and biosimilars (in Slovak)

EJHP podcast

Content provided by BMJ Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BMJ Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

10y ago 3:00

MP3•Episode home

Archived series ("Inactive feed" status)

When? This feed was archived on January 09, 2024 06:09 (4M ago). Last successful fetch was on September 21, 2022 13:20 (1+ y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Dr Juraj Sykora works at the National Cancer Institution, is an associate editor of EJHP and faculty member for EAHP. Here he discusses EAHP 2014, innovation and biosimilars.

This podcast is in Slovak, and was recorded at EAHP 2014.

22 episodes

#Medicine #Science #European #Association #Pharmacy #Practice #Eahp #Arnold #Vulto #BMJ Group #Health and Well-Being #Hospitality #Journalism #EJHP